Applying C. elegans to the Industrial Drug Discovery Process to Slow Aging.
Applying C. elegans to the Industrial Drug Discovery Process to Slow Aging.
复制标题
DOI:
10.3389/fragi.2021.740582
复制
发表时间:
2021
影响因子:
--
通讯作者:
Zavagno, Giulia
中科院分区:
文献类型:
--
作者:
Weinkove, David;Zavagno, Giulia
The increase in our molecular understanding of the biology of aging, coupled with a recent surge in investment, has led to the formation of several companies developing pharmaceuticals to slow aging. Research using the tiny nematode worm Caenorhabditis elegans was the first to show that mutations in single genes can extend lifespan, and subsequent research has shown that this model organism is uniquely suited to testing interventions to slow aging. Yet, with a few notable exceptions, C. elegans is not in the standard toolkit of longevity companies. Here we discuss the paths to overcome the barriers to using C. elegans in industrial drug discovery. We address the predictive power of C. elegans for human aging, how C. elegans research can be applied to specific challenges in the typical drug discovery pipeline, and how standardised and quantitative assays will help C. elegans fulfil its potential in the biotech and pharmaceutical industry. We argue that correct application of this model and its knowledge base will significantly accelerate progress to slow human aging.
登录
查看更多内容
影响因子:
3.7
作者:
HAYFLICK, L;MOORHEAD, PS
通讯作者:
MOORHEAD, PS
影响因子:
--
作者:
Chen X;Barclay JW;Burgoyne RD;Morgan A
通讯作者:
Morgan A
影响因子:
5.9
作者:
Le, Kim N.;Zhan, Mei;Lu, Hang
通讯作者:
Lu, Hang
DOI:
10.1056/nejmoa1706441
发表时间:
2018-05-03
期刊:
The New England journal of medicine
影响因子:
--
作者:
Egan MF;Kost J;Tariot PN;Aisen PS;Cummings JL;Vellas B;Sur C;Mukai Y;Voss T;Furtek C;Mahoney E;Harper Mozley L;Vandenberghe R;Mo Y;Michelson D
通讯作者:
Michelson D
影响因子:
7.7
作者:
Churgin, Matthew A.;Jung, Sang-Kyu;Fang-Yen, Christopher
通讯作者:
Fang-Yen, Christopher